List of works - Andrea Hinsch

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

scientific article published on 23 September 2019

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

scientific article published on 3 May 2017

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published in Scientific Reports

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

scientific article published on 30 March 2020

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

scientific article published on 16 November 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

scientific article published on 17 November 2016

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

scientific article published on 29 November 2019

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

scientific article published on 04 December 2018

Expression of the immune checkpoint receptor TIGIT in seminoma

scientific article published on 31 May 2019

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

scientific article

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

scientific article

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

scientific article published on 18 March 2015

High B7-H3 expression is linked to increased risk of prostate cancer progression

scientific article published on 10 August 2020

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

scientific article

High RSF1 protein expression is an independent prognostic feature in prostate cancer

scientific article published on 05 November 2019

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High homogeneity of mismatch repair deficiency in advanced prostate cancer

scientific article published on 06 December 2019

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

scientific article published on 19 September 2017

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

scientific article published on 02 May 2019

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

scientific article published on 9 February 2018

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

scientific article published on 14 November 2018

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

scientific article published on 01 January 2020

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

scientific article published on 09 March 2020

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

scientific article published on 13 August 2019

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

scientific article published on 07 March 2017

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

scientific article published on 10 January 2019

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

scientific article published on 05 March 2020

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

scientific article published on 23 December 2019

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

scientific article published on 10 September 2019

SNW1 is a prognostic biomarker in prostate cancer

scientific article published on 01 May 2019

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

scientific article published on 01 July 2019

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published on 17 May 2017

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

scientific article published on 19 August 2017

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer

scientific article published on 18 September 2019

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

scientific article published on 19 September 2019

List of works by Andrea Hinsch

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

Expression of the immune checkpoint receptor TIGIT in seminoma

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

High B7-H3 expression is linked to increased risk of prostate cancer progression

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High RSF1 protein expression is an independent prognostic feature in prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High homogeneity of mismatch repair deficiency in advanced prostate cancer

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

SNW1 is a prognostic biomarker in prostate cancer

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

Upregulation of centromere protein F is linked to aggressive prostate cancers